REMICADE (infliximab) - Changing Lives
Links shared publicly online about this topic.
- 1,221total visits
REMICADE (infliximab) - Changing Lives
View full resource at remicade.com
Tags: Ulcerative Colitis Medication, Arthritis, Rheumatoid Arthritis, Rheumatoid Arthritis Medication, Spondyloarthropathy, Ankylosing Spondylitis, Disease and Condition, Remicade
Most Recently Shared on April 22, 2010 at 5:26 pm By:
By fighting chronic inflammation, Remicade has changed the lives of many people. Read some of their stories. http://bit.ly/ay4LME
Remicade: first biological agent for paediatric ulcerative colitis | MIMS online
mims.co.uk — “The latest pharmaceutical, medical and drugs news on MIMS online” View full resource at mims.co.uk
Most Recently Shared on May 2, 2012 at 8:57 am By:
Remicade (infliximab): first biological agent licensed for paediatric ulcerative colitis: http://t.co/J4o7OTzh #gastroenterology
EMA CHMP issues positive opinion to MSD's REMICADE for treatment of pediatric UC
news-medical.net — “MSD today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) adopted a positive opinion recommending the use of REMICADE (infliximab) in the treatment of severely active ulcerative colitis (UC) in pediatric patients ages 6 to 17 years, who have had an inadequate response to conventional therapy, including corticosteroids and 6-mercaptopurine or azathioprine, or who are intolerant to or have medical contraindications for such therapies.” View full resource at news-medical.net
Most Recently Shared on January 21, 2012 at 9:30 am By:
Arthritis News: EMA CHMP issues positive opinion to MSD's REMICADE for treatment of pediatric UC: MSD today anno... http://t.co/qMuhwKHJ
FDA approves Remicade to treat ulcerative colitis in children - News
virtualmedicalcentre.com — “The U.S. Food and Drug Administration today approved Remicade (infliximab) to treat moderately to severely active ulcerative colitis (UC) in children 6 years and older who have had inadequate response to conventional therapy.” View full resource at virtualmedicalcentre.com
Most Recently Shared on October 9, 2011 at 2:07 pm By:
VirtualMedicalCentre Health Site
FDA approves Remicade to treat ulcerative colitis in children http://t.co/oERwrjn9 #Healthnews
REMICADE® Receives FDA Approval As First Biologic Treatment For Pediatric Ulcerative Colitis
medicalnewstoday.com — “Janssen Biotech, Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved REMICADE® (infliximab) for the treatment of moderately to severely active ulcerative colitis” View full resource at medicalnewstoday.com
Most Recently Shared on September 24, 2011 at 8:05 am By:
Crohn Disease Wisdom OW Health
REMICADE® Receives FDA Approval As First Biologic Treatment For Pediatric Ulcerative Colitis: Janssen Biotech, ... http://t.co/maXFag05
FDA Panel Backs Remicade for Kids With Ulcerative Colitis - QualityPoint Technologies
qualitypointtech.net — “(MedPage Today) -- SILVER SPRING, Md. -- An FDA advisory panel has recommended expanding the indication for infliximab (Remicade) to include treatment of ulcerative colitis in children.” View full resource at qualitypointtech.net
Most Recently Shared on July 21, 2011 at 10:45 pm By:
FDA Panel Backs Remicade for Kids With Ulcerative Colitis: (MedPage Today) -- SILVER SPRING, Md. -- An FDA advisor... http://bit.ly/na9znL
Medical News: FDA Panel Backs Remicade for Kids With Ulcerative Colitis - in Gastroenterology, Inflammatory Bowel Disease from MedPage Today
medpagetoday.com — “SILVER SPRING, Md. -- An FDA advisory panel has recommended expanding the indication for infliximab (Remicade) to include treatment of ulcerative colitis in children.” View full resource at medpagetoday.com
Most Recently Shared on July 21, 2011 at 10:16 pm By:
FDA Panel Backs Remicade for Kids With Ulcerative Colitis http://bit.ly/q09fHV
FDA Panel To Consider Additional Use For Remicade In Pediatric Patients
nasdaq.com — “NASDAQ News: FDA Panel To Consider Additional Use For Remicade In Pediatric Patients” View full resource at nasdaq.com
Most Recently Shared on July 20, 2011 at 12:59 pm By:
Raymond DuBois Physician, Doctor, Internist, Gastroenterologist, and Health Executive
FDA Advisory Panel To Consider Expanding Infliximab For Use In Pediatric Patients: http://t.co/1N5PTXc
Medical News: FDA Gives Positive Review of Colitis Drug in Kids - in Washington-Watch, FDA General from MedPage Today
medpagetoday.com — “WASHINGTON -- Infliximab (Remicade) appears to work just as well in children with ulcerative colitis as it does in adults and doesn't seem to offer any new safety risks, FDA reviewers said.” View full resource at medpagetoday.com
Most Recently Shared on July 19, 2011 at 8:00 pm By:
FDA Gives Positive Review of Colitis Drug in Kids: WASHINGTON (MedPage Today) -- Infliximab… http://goo.gl/fb/GCaVr
Medical News: FDA Gives Positive Review of Colitis Drug in Kids - in Washington-Watch, FDA General from MedPage Today
medpagetoday.com — “WASHINGTON -- Infliximab (Remicade) appears to work just as well in children with ulcerative colitis as it does in adults and doesn't seem to offer any new safety risks, FDA reviewers said.” View full resource at medpagetoday.com
Most Recently Shared on July 19, 2011 at 6:57 pm By:
FDA Gives Positive Review of Colitis Drug in Kids http://bit.ly/obiVs3
FDA Gives Positive Review of Colitis Drug in Kids - QualityPoint Technologies
qualitypointtech.net — “WASHINGTON (MedPage Today) -- Infliximab (Remicade) appears to work just as well in children with ulcerative colitis as it does in adults and doesn't seem to offer any new safety risks, FDA reviewers said.” View full resource at qualitypointtech.net
Most Recently Shared on July 19, 2011 at 6:45 pm By:
FDA Gives Positive Review of Colitis Drug in Kids: WASHINGTON (MedPage Today) -- Infliximab (Remicade) appears to ... http://bit.ly/mSHwRd
Extended use for Remicade in Crohn's disease | MIMS online
mims.co.uk — “The latest pharmaceutical, medical and drugs news on MIMS online” View full resource at mims.co.uk
Most Recently Shared on June 30, 2011 at 1:10 pm By:
Use of Remicade (infliximab) in Crohn's disease broadened: http://t.co/5u9uoRH
Phase 3 Study of Remicade for Ulcerative Colitis in Pediatric Patients - MPR
empr.com — “Centocor Ortho Biotech announced results from its Phase 3 study of Remicade (infliximab) in the treatment of pediatric patients with moderately to severely active ulcerative colitis (UC).” View full resource at empr.com
Most Recently Shared on May 10, 2011 at 3:54 pm By:
MPR News: Phase 3 Study of Remicade for Ulcerative Colitis in Pediatric Patients: Centocor Ortho Biotech announc... http://bit.ly/mK0h6c
Phase 3 Study of Remicade for Ulcerative Colitis in Pediatric Patients - ONA
oncologynurseadvisor.com — “Centocor Ortho Biotech announced results from its Phase 3 study of Remicade (infliximab) in the treatment of pediatric patients with moderately to severely active ulcerative colitis (UC).” View full resource at oncologynurseadvisor.com
Most Recently Shared on May 10, 2011 at 3:36 pm By:
OncologyNurseAdvisor Oncology, Nursing, Medical Education, and Medical Publisher
Phase 3 Study of Remicade for Ulcerative Colitis in Pediatric Patients http://goo.gl/fb/qYVQj
Medical News: BSR: Infliximab May Help in Resistant Arthritis - in Meeting Coverage, BSR from MedPage Today
medpagetoday.com — “BRIGHTON, England -- Infliximab (Remicade) remains an option for patients with longstanding rheumatoid arthritis who have not responded adequately to another tumor necrosis factor (TNF) inhibitor, res” View full resource at medpagetoday.com
Most Recently Shared on April 15, 2011 at 1:11 pm By:
BSR: Infliximab May Help in Resistant Arthritis (CME/CE) http://bit.ly/fF0X61
Supplemental BLA submitted for Remicade for pediatric ulcerative colitis - MPR
empr.com — “Centocor Ortho Biotech announced that it submitted a supplemental Biologics License Application (sBLA) to the FDA for Remicade (infliximab) for the treatment of moderately to severely active ulcerative colitis (UC) in pediatric patients who have had an inadequate response to conventional therapy.” View full resource at empr.com
Most Recently Shared on December 29, 2010 at 4:14 pm By:
MPR News: Supplemental BLA submitted for Remicade for pediatric ulcerative colitis: Centocor Ortho Biotech annou... http://bit.ly/erEMRU
Advertisement
